Quick Links

» CV
» Publications
» Current Research
» Awards

Patricia M. Danzon
Celia Moh Professor, Professor of Health Care Management


Education

PhD, University of Chicago, 1973; MA, University of Chicago, 1969; BA, University of Oxford, 1968

Recent Consulting

Pharmaceutical regulation (Pfizer, Merck, Aventis etc.), 1994-present; Insurance regulation, Alliance of American Insurers, 1977-93, Insurance Services Office, 1988-95; Medical malpractice, American Medical Association, American Hospital Association, The Rand Corporation, 1984-94; Health Insurance, Health Insurance Association of America, Government of New Zealand, 1990-94, World Bank, Asian Development Bank

Career and Recent Professional Awards; Teaching Awards

Institute of Medicine; Research Associate, National Bureau of Economic Research; National Academies, Policy & Global Affairs Oversight Board; National Institutes of Health, Fogarty International Center Advisory Board, 2004–2008; Robert C. Witt Research Award, American Risk and Insurance Association, 1995; Elizur Wright Award, American Risk and Insurance Association, 1988

Academic Positions Held

Wharton: 1985-present (Chairperson, Health Care Systems Department, 2004-2008; 1994-97; named Celia Z. Moh Professor, 1991). Previous appointment: Duke University. Visiting appointments: University of Chicago; Australian National University; Victoria University, New Zealand

Other Positions

Senior Research Fellow, Hoover Institution, 1980-84; Research Economist, The Rand Corporation, 1974-80

Professional Leadership 2005-2009

Associate Editor, Journal of Health Economics; Policy Board Member, Office of Health Economics, London; Associate Editor, International Journal of Health Care Finance;

Corporate and Public Sector Leadership 2005-2009

Board of Directors, Medarex Inc.; National Academy of Social Insurance; GAVI, Economic Expert Group on Advance Market Commitment for Pneumococcal Vaccine, 2007-8.

For more information, go to My Personal Page

Publications
Patricia M. Danzon, Adrian Towse, Andrew W. Mulcahy (2011), Setting Cost-Effectiveness Thresholds As A Means To Achieve Appropriate Drug Prices In Rich And Poor Countries, Health Affairs, 30(8): 1529-38
Patricia M. Danzon, Nuno S. Pereira (2011), Vaccine Supply: Effects of Regulation and Competition, NBER Working Paper Series
Patricia M. Danzon, Michael F. Furukawa (2011), Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets, NBER Working Paper Series
Patricia M. Danzon, Andrew Mulcahy, Adrian K. Towse (2011), Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement, NBER Working Paper Series
Patricia M. Danzon, Scott J. Johnson, Genia Long, Michael F. Furukawa (2011), Commercial Importation of Prescription Drugs in the US: Short-run Implictions., Journal of Health Politics, Policy and Law, 36.2: 295 - 316. April 2011.

View More  

top of page

Current Research
Patricia M. Danzon, Andrew Epstein, Sean Nicholson 2004, Mergers and Acquisitions in the Pharmaceutical and Biotech Industries
Patricia M. Danzon, Michael Furukawa 2001, New Evidence on International Price Comparisons.

top of page

Honors And Awards
American Risk and Insurance Association, Award for Outstanding Article. “Alternative Liability Regimes for Medical Injuries: Evidence from Simulation Analysis.”, 1995
American Association of Risk and Insurance, Award for Outstanding Article. “Occupational Disease: Evaluating the Options,” Journal of Risk and Insurance, 1987-1988
American Risk and Insurance Association, Elizur Wright Award, for Medical Malpractice: Theory, Evidence and Public Policy, 1987

top of page

 
 
Danzon M. Patricia
Patricia M. Danzon
204 Colonial Penn Center
3641 Locust Walk
Philadelphia, PA 19104
Phone: (215) 898-5722
danzon@wharton.upenn.edu

Personal Website

Research Interests:
Health care; biopharmaceuticals; insurance; liability; medical malpractice; industrial organization